Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva, Cephalon Ask European Union Regulators to Approve Deal
Bloomberg
Friday, August 26, 2011 - 9:14am
tags:
Teva Pharmaceuticals, Cephalon, Europe, M&A
New Jersey's Par Pharmaceutical to Pay $154M to Settle Medicaid Fraud Allegations
Becker's ASC Review
Thursday, August 25, 2011 - 9:45pm
tags:
Medicare fraud, Par Pharmaceutical
Twenty Seconds Pit Glaxo Against Pfizer in India’s Drug Market
Bloomberg
Thursday, August 25, 2011 - 9:38pm
tags:
GSK, Pfizer, India, drug reps
Can Jazz Pharmaceuticals Play Through Its Recent Volatility?
Investors.com
Thursday, August 25, 2011 - 3:45pm
tags:
Jazz Pharmaceuticals
Buying Into a Hot Hepatitis C Drug Market
Minyanville
Thursday, August 25, 2011 - 3:44pm
tags:
hepatitis C, Pharmasset, Vertex, Merck, Achillion, Indenix, Inhibitex, INX-189, Incivek, Victrelis
Revs Rise at Immunomedics in Q4
Yahoo/Zacks.com
Thursday, August 25, 2011 - 3:41pm
tags:
earnings, Immunomedics
Shire wins FDA approval for rare disease drug
Bizjournals.com
Thursday, August 25, 2011 - 1:29pm
tags:
FDA, hereditary angiodema, Shire, Firazyr
Lilly, Boehringer diabetes drug Trajenta receives European marketing approval
Yahoo/AP
Thursday, August 25, 2011 - 1:28pm
tags:
Eli Lilly, Boehringer Ingelheim, diabetes, Europe, Trajenta
6 Micro-Cap Biotech Stocks Enjoying Winning Streaks
Seeking Alpha
Thursday, August 25, 2011 - 12:23pm
tags:
BioTime, China Biologic, Oncolytics, Cornerstone Therapeutics, Obagi Medical Products, CompuGen
Good News for Cell Therapeutics
Yahoo/Zacks.com
Thursday, August 25, 2011 - 12:20pm
tags:
Cell Therapeutics, pixantrone, non-Hodgkin's lymphoma, Europe
Charles River to Align Segments
Yahoo/Zacks.com
Thursday, August 25, 2011 - 12:16pm
tags:
Charles River Laboratories, restructuring
Axis-Shield Recommends Rejection of Alere’s Takeover Offer
Bloomberg
Thursday, August 25, 2011 - 12:01pm
tags:
Alere, Axis-Shield, M&A
Payers expect Provenge sales to stay flat
Fierce Pharma
Thursday, August 25, 2011 - 11:49am
tags:
Dendreon, Provenge, prostate cancer
Biotech Clinical Trials Update
Seeking Alpha
Thursday, August 25, 2011 - 11:48am
tags:
IPX066, Treprostinil, United Therapeutics, Impax, GSK, clinical trials
Glaxo Reps Ask Supreme Court To Review Overtime
Pharmalot
Thursday, August 25, 2011 - 8:25am
tags:
GSK, overtime lawsuits, Supreme Court
Analyst upgrades drugmaker Elan on higher expectations for multiple sclerosis drug Tysabri
Yahoo/AP
Thursday, August 25, 2011 - 8:24am
tags:
Elan, Biogen Idec, MS, Tysabri, multiple sclerosis
A Bigger World Means Bigger Profits For Mead Johnson
Seeking Alpha
Thursday, August 25, 2011 - 8:22am
tags:
infant formula, Mead Johnson, Abbott Laboratories, JNJ
Dividend Report Card: Johnson & Johnson
Motley Fool
Thursday, August 25, 2011 - 8:19am
tags:
JNJ, dividends
Docs like pharma dinners--with a few caveats
Fierce Pharma
Wednesday, August 24, 2011 - 10:05pm
tags:
physicians
Botox: ‘A Pipeline in a Vial’
NY Times, NY
Wednesday, August 24, 2011 - 10:03pm
tags:
Botox, Allergan, migraines, urinary incontinence

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.